Cytostatika 2024-Ii Tender, Czech Republic - 98381135

Procurement Summary

Country : Czech Republic

Summary : Cytostatika 2024-Ii

Deadline : 08 Apr 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 98381135

Document Ref. No. : 140146-2024

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : CZK 16720000

Purchaser's Detail

Purchaser : UNIVERSITY HOSPITAL IN PILSEN
Address: Edvarda Beneše 1128
Town: Plzeň
NUTS-Code: CZ032
Postal Code: 30100
Phone: 420 603366059
Czech Republic
Email :kozak@fnplzen.cz
URL :https://www.fnplzen.cz

Tender Details

The subject of the public order is the supply of medicinal products intended for the therapy of malignant diseases in the total expected volume of 262, 960 individual doses of medicinal products.

Delivery of the subject of performance budou implemented on the basis of the results of the completed procurement procedure for a period of four years from the signing of the purchase contract.

Cytostatic agent containing the active substance ixazomib

P. o. form containing 4 mg of ixazomib per form unit, expected annual volume of 60 form units (doses); ATC L01XG03

Cytostatic agent containing ucnn substances trametinib

P. o. a form containing 2 mg of trametinib in a form unit, expected annual volume of 4, 200 form units (doses); ATC L01EE01

Cytostatic containing the active substance ribociclib

P. o. form containing 200 mg of ribociclib per form unit, expected annual volume of 18, 900 form units(dose); ATC J01EF02

Cytostatic agent containing the active substance encorafenib

P. o. form containing 75 mg of encorafenib in a form unit, expected annual volume of 10, 920 form units (doses); ATC L01EC03

Cytostatic containing the active substance binimetinib

P. o. form containing 15 mg of binimetinib in the for unitwe, expected annual volume of 7, 560 units of form (doses); ATC L01EE03

Cytostatic drug containing the active substance ruxolitinib

P. o. a form containing 20 mg of ruxolitinib in a form unit, expected annual volume of 2, 800 form units (doses); ATC L01EJ01

Cytostatic drug containing the active substance ponatinib

P. o.f...
Document Type: Contract Notice
Reference Number: 27/24
Contract Type: supplies
Estimated Value: 16720000 - CZK
Authority Type: pub-undert-cga
Doc Title: Cytostatika 2024-II
Dispatch Date: 2024-03-06
Publish Date: 2024-03-07
Submission Date: 2024-04-08

Documents

 Tender Notice